Intensity Therapeutics (INTS) announces that INT230-6 achieved complete responses in a murine models of Malignant Peripheral Nerve Sheath Tumor. In a study conducted in the Staedtke-Bai laboratory at Johns Hopkins University, at 21 days, animals tested with INT230-6 all achieved a complete response, whereas all animals’ tumors in the control group continued to grow.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.